Company / Operating Income per Share
Entrada Therapeutics, Inc. Operating Income per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$1.25
FY2025
5-year range
-$3.10 / $1.25
FY2023-FY2025
Trend
+1423.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed +1423% YoY in FY2025, a notable deviation from the 2-year average annual change of +760%.
Based on SEC 10-K filings.
1.25 in FY2025.
Improved from $-3.10 to $1.25 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 1423.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.03 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.25 | +1423.0% |
| FY2024 | -$0.09 | +96.9% |
| FY2023 | -$3.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026